0
December 23 2009, Vol 302, No. 24 >

Full Content is available to subscribers

Subscribe/Learn More
Lab, Field, and Clinic | December 23 2009

Promising Antibody Fights Lethal Viruses

Rebecca Voelker
JAMA. 2009;302(24):2643. doi:10.1001/jama.2009.1843.
Text Size: A A A
Published online
Article
Figures

Extract

Little more than a decade ago, Nipah virus was not even a blip on the world's infectious diseases radar. But all that changed in 1999. Nipah emerged as a newly discovered pathogen in a Malaysian outbreak of viral encephalitis among pigs and pig farmers that claimed 105 human lives.

Nipah and its close relative, Hendra virus, still are somewhat obscure organisms. But their highly pathogenic nature—Nipah's human mortality rate reaches 75% and, in small outbreaks, has been 100%—has put researchers on a fast track to develop a therapeutic agent capable of treating infection with both viruses.
Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption

Grahic Jump LocationImage not available.

The Pteropus genus of bats is the natural reservoir for deadly Nipah and Hendra viruses.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Letters

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
From JAMA ’s Daily News Site
JAMA. 2013;309(20):2086. doi:10.1001/jama.2013.6020.
Related Topics
Jobs

More Listings at
JAMACareerCenter.com >

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems